2012
DOI: 10.1111/joic.12003
|View full text |Cite
|
Sign up to set email alerts
|

One‐Year Outcome of Small‐Vessel Disease Treated with Sirolimus‐Eluting Stents: A Subgroup Analysis of the e‐SELECT Registry

Abstract: Objectives: To investigate the characteristics and one-year outcomes following sirolimus-eluting CYPHER Select Plus stent (SES) implantation in small (SmVD) and non-small vessel disease (NSmVD) in the international

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 60 publications
0
1
0
Order By: Relevance
“…[8] Instead, the higher incidence rates of stent thrombosis were associated with the 2.5 mm platforms. [9] One of the major concerns for polymeric BRSs is their mechanical performance, especially their interaction with blood vessels during and after deployment. Agrawal et al [10] carried out the earliest work in assessing the in vitro performance of the Duke biodegradable stents made of Poly-L lactide (PLLA) fibres.…”
Section: Introductionmentioning
confidence: 99%
“…[8] Instead, the higher incidence rates of stent thrombosis were associated with the 2.5 mm platforms. [9] One of the major concerns for polymeric BRSs is their mechanical performance, especially their interaction with blood vessels during and after deployment. Agrawal et al [10] carried out the earliest work in assessing the in vitro performance of the Duke biodegradable stents made of Poly-L lactide (PLLA) fibres.…”
Section: Introductionmentioning
confidence: 99%